From the Department of Medicine, University of Texas-Houston, Houston, TX.
Departments of Medicine and Cardiology, New York Medical College/Westchester Medical Center, Valhalla, NY.
Cardiol Rev. 2021;29(6):285-288. doi: 10.1097/CRD.0000000000000409.
As the global coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory distress syndrome coronavirus 2 continues to cause higher mortality and hospitalization rates among older adults, strategies such as frailty screening have been suggested for resource allocation and clinical management. Frailty is a physiologic condition characterized by a decreased reserve to stressors and is associated with disability, hospitalization, and death. Measuring frailty can be a useful tool to determine the risk and prognosis of COVID-19 patients in the acute setting, and to provide higher quality of care for vulnerable individuals in the outpatient setting. A literature review was conducted to examine current research regarding frailty and COVID-19. Frailty can inform holistic care of COVID-19 patients, and further investigation is needed to elucidate how measuring frailty should guide treatment and prevention of COVID-19.
随着由严重急性呼吸综合征冠状病毒 2 引起的全球冠状病毒病-19(COVID-19)大流行继续导致老年人的死亡率和住院率上升,人们提出了虚弱筛查等策略,以进行资源分配和临床管理。虚弱是一种生理状况,其特征是对压力源的储备减少,与残疾、住院和死亡有关。测量虚弱程度可以作为一种有用的工具,用于确定急性疾病 COVID-19 患者的风险和预后,并为门诊环境中的脆弱个体提供更高质量的护理。进行了文献回顾,以研究关于虚弱和 COVID-19 的当前研究。虚弱可以为 COVID-19 患者的整体护理提供信息,需要进一步研究来阐明如何衡量虚弱程度来指导 COVID-19 的治疗和预防。